Ryan Specialty (NYSE:RYAN) Downgraded by Wolfe Research

Ryan Specialty (NYSE:RYAN) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating in a research report issued to clients and investors on Monday, Marketbeat Ratings reports.

Several other analysts also recently commented on the company. JMP Securities reiterated a “market perform” rating on shares of Ryan Specialty in a research note on Monday, April 15th. Citigroup lifted their price objective on Ryan Specialty from $49.00 to $52.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. JPMorgan Chase & Co. upped their target price on shares of Ryan Specialty from $47.00 to $49.00 and gave the company an “underweight” rating in a research note on Monday, April 8th. Wells Fargo & Company lifted their price target on shares of Ryan Specialty from $57.00 to $58.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. Finally, Keefe, Bruyette & Woods increased their price objective on shares of Ryan Specialty from $56.00 to $62.00 and gave the company an “outperform” rating in a research report on Wednesday, April 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Ryan Specialty presently has a consensus rating of “Hold” and a consensus target price of $54.25.

Ryan Specialty Price Performance

RYAN opened at $52.18 on Monday. The firm has a market cap of $13.58 billion, a PE ratio of 98.45 and a beta of 0.58. The stock has a 50-day moving average price of $52.65 and a 200-day moving average price of $47.13. Ryan Specialty has a 1 year low of $39.44 and a 1 year high of $56.51. The company has a debt-to-equity ratio of 1.98, a current ratio of 1.16 and a quick ratio of 1.16.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.35 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.35. Ryan Specialty had a net margin of 9.15% and a return on equity of 46.11%. The business had revenue of $552.00 million during the quarter, compared to analyst estimates of $549.06 million. During the same period last year, the business earned $0.26 EPS. Ryan Specialty’s revenue was up 20.6% compared to the same quarter last year. Sell-side analysts predict that Ryan Specialty will post 1.77 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of RYAN. PNC Financial Services Group Inc. raised its holdings in Ryan Specialty by 192.0% in the 3rd quarter. PNC Financial Services Group Inc. now owns 549 shares of the company’s stock worth $27,000 after purchasing an additional 361 shares during the period. Parkside Financial Bank & Trust increased its position in Ryan Specialty by 1,283.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,010 shares of the company’s stock worth $43,000 after buying an additional 937 shares in the last quarter. Intelligent Financial Strategies bought a new position in shares of Ryan Specialty in the first quarter worth about $44,000. Benjamin F. Edwards & Company Inc. purchased a new position in shares of Ryan Specialty during the 1st quarter valued at about $45,000. Finally, Operose Advisors LLC purchased a new stake in Ryan Specialty in the 3rd quarter worth approximately $92,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.